YIH
RYTM icon

Y-Intercept (HK)’s Rhythm Pharmaceuticals RYTM Stock Holding History

Y-Intercept (HK)’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$880K Buy
+7,925
New +$717K 0.02% 1098
2025
Q2 		– Sell
-5,966
Closed -$316K – 1964
2025
Q1 		$316K Buy
5,966
+100
+2% +$5.55K 0.02% 888
2024
Q4 		$328K Buy
+5,866
New +$324K 0.02% 905

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Y-Intercept (HK)'s RYTM Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 7,925 shares worth $880K. The stake represents 0.02% of the portfolio and ranks #1098 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in RYTM as recently as Q1 2025.

Y-Intercept (HK) first reported a position in RYTM in Q4 2024 and has held it in 3 quarters since. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Y-Intercept (HK) held 7,925 shares of Rhythm Pharmaceuticals worth $880K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Y-Intercept (HK) position in Q2 2026.
  • Rhythm Pharmaceuticals made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1098 holding.
  • Y-Intercept (HK) first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.